Trials / Conditions / Intermittent Explosive Disorder

Intermittent Explosive Disorder

14 registered clinical trials studyying Intermittent Explosive Disorder — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Inflammatory Challenge in Human Aggression. NCT06665074	Ohio State University	Phase 2
Recruiting	Pimavanserin and Aggression and Social Cognition. NCT05895513	Ohio State University	Phase 2
Unknown	Maladaptive Anger Treatment NCT06275607	The University of Texas at San Antonio	N/A
Recruiting	Neural Correlates During Alcohol Intoxication NCT06118580	Ohio State University	Phase 2
Recruiting	Effect of Nitrous Oxide on Aggression. NCT06118567	Ohio State University	Phase 2
Unknown	A Cognitive Bias Modification RCT for Aggression NCT04819230	Temple University	N/A
Terminated	Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive NCT03420222	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 2
Completed	Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder NCT02055638	Azevan Pharmaceuticals	Phase 1 / Phase 2
Completed	Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder NCT02048241	New York State Psychiatric Institute	Phase 4
Terminated	Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment NCT00282165	UMC Utrecht	Phase 4
Completed	Psychotherapy for Intermittent Explosive Disorder NCT00667212	University of Chicago	N/A
Completed	A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder NCT00078754	University of Chicago	Phase 2
Completed	A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED NCT00127400	University of Chicago	Phase 2
Completed	Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. NCT00399698	Ohio State University	Phase 3